Caliper Q2 Revenues Bounce 32 Percent on Strong Research Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Driven by its Research business, Califer Life Sciences reported after the close of the market on Tuesday a 32 percent year-over-year increase in revenues for the second quarter.

For the three months ended June 30, total revenues climbed to $38.3 million, up from $29.1 million a year ago. Organically, revenues grew 23 percent year over year, the company said.

Wall Street had expected $34.4 million in total revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.